The management of systemic inflammation has entered a new era, characterized by a shift from broad-spectrum immunosuppression to highly targeted biological interventions. As healthcare providers integrate advanced diagnostic imaging like PET-CT and MRI angiography, the ability to detect vascular wall thickening at earlier stages has significantly improved patient outcomes. This transition is a...
English